Zuzana Chyra
- Hematology top 10%
- Multiple Myeloma Research and Treatments 19
-
- Peptidase Inhibition and Analysis 4
- CAR-T cell therapy research 3
-
- Chronic Lymphocytic Leukemia Research 5
-
- Protein Degradation and Inhibitors 9
- Amyloidosis: Diagnosis, Treatment, Outcomes 5
- Ubiquitin and proteasome pathways 3
-
- Cancer Mechanisms and Therapy 3
- Co-authors
- Roman HájekTomáš Jelı́nekMatouš HrdinkaTereza ŠevčíkováPetr KuglíkJan SmetanaChristopher P. WardellBrian A. Walker
- Cited by
- HematologyOncologyGenetics
- Journals
- Nature Communications (1 paper)Blood (9 papers)International Journal of Molecular Sciences (1 paper)
- Partner nations
- CzechiaUnited StatesItaly
In The Last Decade
Zuzana Chyra
27 papers receiving 275 citations
Peers
Comparison fields: 5 of 46
- Hematology 127
- Oncology 109
- Genetics 38
- Molecular Biology 170
- Otorhinolaryngology 9
Countries citing papers authored by Zuzana Chyra
This map shows the geographic impact of Zuzana Chyra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zuzana Chyra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zuzana Chyra more than expected).
Fields of papers citing papers by Zuzana Chyra
This network shows the impact of papers produced by Zuzana Chyra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zuzana Chyra. The network helps show where Zuzana Chyra may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zuzana Chyra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 15 | |
| 3 | 2024 | 17 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 17 | |
| 7 | 2023 | 11 | |
| 8 | 2023 | 4 | |
| 9 | 2023 | 30 | |
| 10 | 2022 | 16 | |
| 11 | 2022 | 10 | |
| 12 | 2021 | 4 | |
| 13 | 2019 | 0 | |
| 14 | 2019 | 1 | |
| 15 | 2017 | 64 | |
| 16 | 2017 | 7 | |
| 17 | 2016 | 3 | |
| 18 | 2016 | 25 | |
| 19 | 2015 | 10 | |
| 20 | Souhrn doporučení 2013 "Diagnostika a léčba systémové AL amyloidózy" | 2013 | 0 |
About Zuzana Chyra
Zuzana Chyra is a scholar working on Hematology, Genetics and Oncology, having authored 31 papers that have together received 279 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (19 papers), Protein Degradation and Inhibitors (9 papers), Chronic Lymphocytic Leukemia Research (5 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (5 papers), Peptidase Inhibition and Analysis (4 papers), Cancer Mechanisms and Therapy (3 papers), CAR-T cell therapy research (3 papers) and Ubiquitin and proteasome pathways (3 papers). The work is most often cited by research in Hematology (127 citations), Oncology (109 citations) and Genetics (38 citations). Zuzana Chyra has collaborated with scholars based in Czechia, United States and Italy. Frequent co-authors include Roman Hájek, Tomáš Jelı́nek, Matouš Hrdinka, Tereza Ševčíková, Petr Kuglík, Jan Smetana, Christopher P. Wardell, Brian A. Walker, Viera Sandecká and Martina Almáši. Their work appears in journals such as Nature Communications, Blood and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.